To include your compound in the COVID-19 Resource Center, submit it here.

EMA validates MAA for binimetinib/encorafenib in melanoma

Pierre Fabre Group (Castres, France) said EMA validated an MAA for binimetinib (MEK162)

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE